BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11584719)

  • 1. [Manifestations of primary vasculitis in the ENT region].
    Paulsen JI; Rudert H
    Z Rheumatol; 2001 Aug; 60(4):219-25. PubMed ID: 11584719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic ANCA-associated vasculitis--diagnosis and therapy].
    Eisenberger U; Hess C
    Ther Umsch; 2008 May; 65(5):295-301. PubMed ID: 18622935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Wegener's granulomatosis in the head and neck region].
    Gottschlich S; Ambrosch P; Gross WL; Hellmich B
    HNO; 2004 Oct; 52(10):935-45; quiz 946-7. PubMed ID: 15309321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 1. Systemic aspects, pathogenesis and clinical aspects].
    Gross WL; Reinhold-Keller E
    Z Rheumatol; 1995; 54(5):279-90. PubMed ID: 8578884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCA-associated vasculitis: diagnosis, clinical characteristics and treatment.
    Haubitz M
    Vasa; 2007 May; 36(2):81-9. PubMed ID: 17708098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary systemic vasculitis: clinical features and mortality.
    Lane SE; Watts RA; Shepstone L; Scott DG
    QJM; 2005 Feb; 98(2):97-111. PubMed ID: 15655098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe.
    Ito-Ihara T; Muso E; Kobayashi S; Uno K; Tamura N; Yamanishi Y; Fukatsu A; Watts RA; Scott DG; Jayne DR; Suzuki K; Hashimoto H
    Clin Exp Rheumatol; 2008; 26(6):1027-33. PubMed ID: 19210866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.
    Tidman M; Olander R; Svalander C; Danielsson D
    J Intern Med; 1998 Aug; 244(2):133-41. PubMed ID: 10095799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of patients with granulomatosis with polyangiitis and microscopic polyangiitis in ENT practice: a comparative analysis.
    Wojciechowska J; KręCicki T
    Acta Otorhinolaryngol Ital; 2018 Dec; 38(6):517-527. PubMed ID: 30623897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of ANCA-positive systemic vasculitis with intravenous immunoglobins].
    Mouthon L
    Rev Med Interne; 1999; 20 Suppl 4():431s-435s. PubMed ID: 10522318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostics and therapy of antineutrophil cytoplasmic antibody (ANCA) associated vasculitides.
    Reinhold-Keller E
    Curr Pharm Des; 2012; 18(29):4537-41. PubMed ID: 22612757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
    Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
    Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update in the diagnosis and management of pulmonary vasculitis.
    Frankel SK; Cosgrove GP; Fischer A; Meehan RT; Brown KK
    Chest; 2006 Feb; 129(2):452-465. PubMed ID: 16478866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Wegener's granulomatosis and microscopic polyangiitis].
    de Groot K; Reinhold-Keller E
    Z Rheumatol; 2009 Feb; 68(1):49-63; quiz 64. PubMed ID: 19184066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.
    Fienberg R; Mark EJ; Goodman M; McCluskey RT; Niles JL
    Hum Pathol; 1993 Feb; 24(2):160-8. PubMed ID: 8381764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature.
    Sørensen SF; Slot O; Tvede N; Petersen J
    Ann Rheum Dis; 2000 Jun; 59(6):478-82. PubMed ID: 10834866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood.
    Cabral DA; Uribe AG; Benseler S; O'Neil KM; Hashkes PJ; Higgins G; Zeft AS; Lovell DJ; Kingsbury DJ; Stevens A; McCurdy D; Chira P; Abramson L; Arkachaisri T; Campillo S; Eberhard A; Hersh AO; Huber AM; Kim S; Klein-Gitelman M; Levy DM; Li SC; Mason T; Dewitt EM; Muscal E; Nassi L; Reiff A; Schikler K; Singer NG; Wahezi D; Woodward A;
    Arthritis Rheum; 2009 Nov; 60(11):3413-24. PubMed ID: 19877069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary manifestations of the vasculitides].
    Cordier JF
    Rev Prat; 2008 Mar; 58(5):492-8. PubMed ID: 18524105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.